Status:
COMPLETED
Feasibility of Tight Blood Glucose Control With the Space TGC System in Surgical ICU Patients
Lead Sponsor:
B. Braun Melsungen AG
Conditions:
Critical Illness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hyperglycemia is common in critically ill patients and associated with an adverse outcome. Thus, glycaemic control is an important issue in critical care. Despite extensive efforts of the intensive ca...
Eligibility Criteria
Inclusion
- Inclusion:
- age: \> 18 years of age
- stay in the ICU expected to be \> 20 h
- blood glucose \> 110 mg/dl or patient on insulin treatment
- Exclusion:
- patients with hyperglycaemic crisis/ketoacidosis due to insulin deficiency.
- known or suspected allergy to insulin
- any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient (i.e., liver failure, other fatal organ failures)
- moribund patients likely to die within 24 hours
Exclusion
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01146847
Start Date
December 1 2009
End Date
June 1 2010
Last Update
November 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Ludwigshafen am Rhein gGmbH, Klinik für Anästhesiologie und Operative Intensivmedizin
Ludwigshafen, Germany, 67063